These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 1409827)

  • 1. Availability of phenindione-beta-cyclodextrin inclusion complex.
    Tous SS; el-Sayed AM; el-Harras SA; Jun HW
    Pharmazie; 1992 May; 47(5):365-8. PubMed ID: 1409827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preparation and characterization of simvastatin/hydroxypropyl-beta-cyclodextrin inclusion complex using supercritical antisolvent (SAS) process.
    Jun SW; Kim MS; Kim JS; Park HJ; Lee S; Woo JS; Hwang SJ
    Eur J Pharm Biopharm; 2007 Jun; 66(3):413-21. PubMed ID: 17240129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inclusion complexes of tadalafil with natural and chemically modified beta-cyclodextrins. I: preparation and in-vitro evaluation.
    Badr-Eldin SM; Elkheshen SA; Ghorab MM
    Eur J Pharm Biopharm; 2008 Nov; 70(3):819-27. PubMed ID: 18655829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro and in vivo evaluation of an amylobarbitone/hydroxypropyl-beta-cyclodextrin complex prepared by a freeze-drying method.
    Fathy M; Sheha M
    Pharmazie; 2000 Jul; 55(7):513-7. PubMed ID: 10944779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improvement of dissolution properties of furosemide by complexation with beta-cyclodextrin.
    Ozdemir N; Ordu S
    Drug Dev Ind Pharm; 1998 Jan; 24(1):19-25. PubMed ID: 15605593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inclusion complex of trimethoprim with beta-cyclodextrin.
    Li N; Zhang YH; Wu YN; Xiong XL; Zhang YH
    J Pharm Biomed Anal; 2005 Sep; 39(3-4):824-9. PubMed ID: 16011886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improvement of some pharmaceutical properties of drugs by cyclodextrin complexation. 5. Theophylline.
    Ammar HO; Ghorab M; El-nahhas SA; Omar SM; Ghorab MM
    Pharmazie; 1996 Jan; 51(1):42-6. PubMed ID: 8999434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancement of bioavailability of griseofulvin by its complexation with beta-cyclodextrin.
    Dhanaraju MD; Kumaran KS; Baskaran T; Moorthy MS
    Drug Dev Ind Pharm; 1998 Jun; 24(6):583-7. PubMed ID: 9876628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dissolution properties and characterization of halofantrine-2-hydroxypropyl-beta-cyclodextrin binary systems.
    Onyeji CO; Omoruyi SI; Oladimeji FA
    Pharmazie; 2007 Nov; 62(11):858-63. PubMed ID: 18065103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complexation of tanshinone IIA with 2-hydroxypropyl-beta-cyclodextrin: effect on aqueous solubility, dissolution rate, and intestinal absorption behavior in rats.
    Wang L; Jiang X; Xu W; Li C
    Int J Pharm; 2007 Aug; 341(1-2):58-67. PubMed ID: 17482783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preformulation study of the inclusion complex warfarin-beta-cyclodextrin.
    Zingone G; Rubessa F
    Int J Pharm; 2005 Mar; 291(1-2):3-10. PubMed ID: 15707726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of the 13-cis-retinoic acid/cyclodextrin inclusion complexes by phase solubility, photostability, physicochemical and computational analysis.
    Yap KL; Liu X; Thenmozhiyal JC; Ho PC
    Eur J Pharm Sci; 2005 May; 25(1):49-56. PubMed ID: 15854800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inclusion complexes of noscapine in beta-cyclodextrin offer better solubility and improved pharmacokinetics.
    Madan J; Dhiman N; Parmar VK; Sardana S; Bharatam PV; Aneja R; Chandra R; Katyal A
    Cancer Chemother Pharmacol; 2010 Feb; 65(3):537-48. PubMed ID: 19597818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation and characterization of inclusion complex of norflurazon and beta-cyclodextrin to improve herbicide formulations.
    Villaverde J; Morillo E; Pérez-Martínez JI; Ginés JM; Maqueda C
    J Agric Food Chem; 2004 Feb; 52(4):864-9. PubMed ID: 14969543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Solubility enhancement of celecoxib using beta-cyclodextrin inclusion complexes.
    Rawat S; Jain SK
    Eur J Pharm Biopharm; 2004 Mar; 57(2):263-7. PubMed ID: 15018983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancement of dissolution and oral bioavailability of gliquidone with hydroxy propyl-beta-cyclodextrin.
    Sridevi S; Chauhan AS; Chalasani KB; Jain AK; Diwan PV
    Pharmazie; 2003 Nov; 58(11):807-10. PubMed ID: 14664337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Preparation of inclusion complex of paeonol and beta-cyclodextrin by sealed-control temperature method].
    Wang QF; Fan XW; Xu L; Yao Y
    Zhongguo Zhong Yao Za Zhi; 2007 Feb; 32(3):218-21. PubMed ID: 17432142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Solid-state characterization and dissolution properties of bicalutamide-beta-cyclodextrin inclusion complex.
    Patil AL; Pore YV; Kuchekar BS; Late SG
    Pharmazie; 2008 Apr; 63(4):282-5. PubMed ID: 18468387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies on solubility and hypoglycemic activity of gliclazide beta-cyclodextrin-hydroxypropylmethylcellulose complexes.
    Aggarwal S; Singh PN; Mishra B
    Pharmazie; 2002 Mar; 57(3):191-3. PubMed ID: 11933849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Physicochemical characteristics and bioavailability of a novel intestinal metabolite of ginseng saponin (IH901) complexed with beta-cyclodextrin.
    Lee PS; Han JY; Song TW; Sung JH; Kwon OS; Song S; Chung YB
    Int J Pharm; 2006 Jun; 316(1-2):29-36. PubMed ID: 16574357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.